跳至主要内容
临床试验/NL-OMON49141
NL-OMON49141已完成不适用

*A pilot study to assess the safety and feasibility of fluorescent sentinel lymph node identification in colon carcinoma using Indocyanine green and nanocolloid* - FLUOR*ICG*SLN(pilot)

Meander Medisch Centrum0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Oral and written informed consent (IC)
  • - Aged 18 years and older
  • - Pathologically confirmed and/or suspected colon carcinoma

排除标准

  • - Distant metastases
  • - Suspicion of T3-T4 disease based on pre-operative assessment.
  • - Metastatic or T4 disease discovered during intraoperative staging
  • - A tumour too large to pass endoscopically
  • - Pregnant patients
  • - Known allergy to any of the compound used for SLN identification (ICG, Iodine)
  • - Suspected or proven lymph node metastasis
  • - Previous colon surgery
  • - Contra-indication for robotic surgery
  • - Ink marking close to the tumour

研究者

发起方
Meander Medisch Centrum

相似试验